Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
Ye V. Liu, Michael J. Massare, Dale L. Barnard, Thomas Kort, Margret Nathan, Lei Wang, Gale Smith
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV'. Together they form a unique fingerprint.